InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,696.00
(
0.10%
)
Dow Jones
39,753.75
(
0.00%
)
Brent Oil
85.56
(
0.53%
)
Bitcoin
57,276.38
(
-0.13%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120031
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biopharm post# 161345

Monday, 05/20/2013 12:35:39 PM

Monday, May 20, 2013 12:35:39 PM

Post# of 252581

The biotech value worth of Peregrine Pharmaceuticals has just started its rise with the FDA approval for a Phase III NSCLC…

What happened to the Big Pharma partner who was supposed to shepherd Bavituximab through phase-3 and claim ownership of the single most valuable cancer asset in the biotech industry?

No one stepped up the plate, evidently.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up